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Saccharomyces cerevisiae inhibitionThe action of a synthetic antimicrobial peptide analog of Plantaricin 149 (Pln149a) against Saccharomyces
cerevisiae and its interaction with biomembrane model systems were investigated. Pln149a was shown to
inhibit S. cerevisiae growth by more than 80% in YPD medium, causing morphological changes in the yeast
wall and remaining active and resistant to the yeast proteases even after 24 h of incubation. Different
membrane model systems and carbohydrates were employed to better describe the Pln149a interaction with
cellular components using circular dichroism and ﬂuorescence spectroscopies, adsorption kinetics and
surface elasticity in Langmuir monolayers. These assays showed that Pln149a does not interact with either
mono/polysaccharides or zwitterionic LUVs, but is strongly adsorbed to and incorporated into negatively
charged surfaces, causing a conformational change in its secondary structure from random-coil to helix upon
adsorption. From the concurrent analysis of Pln149a adsorption kinetics and dilatational surface elasticity
data, we determined that 2.5 μM is the critical concentration at which Pln149a will disrupt a negative DPPG
monolayer. Furthermore, Pln149a exhibited a carpet-like mechanism of action, in which the peptide initially
binds to the membrane, covering its surface and acquiring a helical structure that remains associated to the
negatively charged phospholipids. After this electrostatic interaction, another peptide region causes a strain
in the membrane, promoting its disruption.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The huge increase in the number of antibiotic-resistant bacteria
calls for the development of new compounds and classes of
antimicrobial agents. Antimicrobial peptides (AMPs) are natural
antimicrobial compounds that have been extensively studied and
suggested as a potential tool for overcoming microbial resistance to
conventional antibiotics. Particular attention has been given to their
application in both the food industry [1,2] and pharmaceuticals [3],
since AMPs seem to play important roles as natural food preservatives
and as the ﬁrst line of defense in many organisms [4].
Lactic acid bacteria produce a large variety of bacteriocins,
proteinaceous compounds with bactericidal activity against a limited
range of microorganisms [5,6]. These compounds are being exten-
sively studied, since most of them are small molecules that can be
easily obtained through chemical synthesis, and their applications
have been widely tested [7].stituto de Física de São Carlos,
400, São Carlos, SP, Brazil. Tel.:
ll rights reserved.Plantaricin 149 (Pln149), YSLQMGATAIKQVKKLFKKKGG, is a
cationic antimicrobial peptide produced by Lactobacillus plantarum
NRIC 149 [8] that has been identiﬁed as a bacteriocin and presents a
narrow inhibitory spectrum that includes genera, species and
subspecies of lactic acid bacteria. A synthetic C-terminal amide analog
(Pln149a) [9] was shown to inhibit Listeria and Staphylococcus strains.
Pln149a is also quite soluble in physiologic conditions and presented
high yield in manual syntheses.
The interaction of antimicrobial peptides and cell membrane
models is widely studied in the literature [10], and three different
mechanisms of action have been established: barrel-stave, when the
peptide recognizes the membrane and oligomerizes in order to form
pores across the membrane; carpet, in which electrostatic interactions
between the peptide and membrane result in local peptide accumula-
tion, disrupting the cell membrane; and toroidal, which involves other
membrane-dependent processes, such as translocation of cytotoxic
peptides across the membrane [11].
Previous studies have described the inhibitory activity of Pln149a
against Listeria and Staphylococcus strains and its interactionwith AOT
(sodium-bis-(2-ethylhexyl)-sulfosuccinate) reverse micelles as a
model for cell membranes [9]. In the present work, these studies
have been extended to elucidate the mechanism by which Pln149a
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against a unicellular fungus, a different class of microorganismwith a
known cellular wall composition.
Based on the its vast usage in the food and pharmaceutical
industries, Saccharomyces cerevisiae was selected as a yeast model to
evaluate the inhibitory growth action of Pln149a and its ability to lyse
the cellular wall. The lysis of yeast cellular walls has biotechnological
applications in several areas, such as the preparation of protoplasts for
genetic improvement in yeast, the treatment of cellular residual yeast
mass from fermentation industries (particularly S. cerevisiae), the
extraction of proteins, enzymes and pigments, the acquisition of
functional carbohydrates from the cellular wall (glucan and mannan)
and the preparation of animal ration. Generally, the lysis is done with
enzymes and/or mechanical rupture of the cells. Neither process is
very economical, since they demand high amounts of enzymes
(lipolytic and glycolytic) and/or mechanical energy [12]. The
possibility of using an antimicrobial peptide like Pln149a to increase
the efﬁciency and to reduce the cost of this process offers new
opportunities for the application of this peptide that was once
expected to be a food-borne pathogenic antibacterial agent [9].
In this sense, this study also focuses on the growth inhibition
promoted by Pln149a on S. cerevisiae cultures, using scanning
electronic microscopy to check the peptide's action on the yeast. In
parallel, a series of model systems were used to simulate the outer
leaﬂet of cell membranes to investigate the interaction of Pln149a
with different phospholipids in both monolayers and vesicles.
Additionally, interactions with different membrane and cell wall
components were also investigated with circular dichroism and
ﬂuorescence spectroscopies in order to observe the surface properties
of the lipid–water interface and the structural changes of the peptide.
2. Materials and methods
2.1. Materials
Reagents and solvents used in synthesis, puriﬁcation and mea-
surements were P.A. grade. All phospholipids were purchased from
Avanti Polar Lipids.
2.2. Peptide synthesis and puriﬁcation
Plantaricin 149 analog (Pln149a) was manually synthesized on
solid phase by Fmoc chemistry, using Rink Amide (4-(2′,4′-
dimethoxyphenyl-Fmoc-aminomethyl phenoxy) resin to prepare
the C-terminal peptide amide. N-Fmoc-protected amino acids were
from NovaBiochem. Couplings were performed by TBTU [N,N,N′,N′-
Tetramethyl-O-(Benzotriazol-1-yl) Uronium Tetraﬂuoroborate], HOBT
(N-Hydroxybenzotriazole) and DIPEA (N,N-Diisopropylethylamine);
deblockings were done with piperidine 20% in DMF, and a mixture of
TFA/TIS/EDT/H2O (94: 2.5: 1: 2.5) (v/v) was used for the ﬁnal
cleavage of the peptide from the resin. After 3 h, the crude peptide
was precipitated in cold diethyl ether, centrifuged and lyophilized. The
peptide puriﬁcation was carried out by dissolving the crude Pln149a
(3 mg/mL) in H2O (0.1% TFA) and performing a reverse phase
chromatography on a YMC-Pack Polymer C18 (250×4.6 mm, 6 μm)
column in an ÄKTA puriﬁer system (GE Healthcare), monitoring
absorbance at 220 nm. The column was previously equilibrated with
H2O (TFA 0.1%) and eluted using a linear gradient from 0 to 70% of
acetonitrile 90% in H2O (TFA 0.1%) over 40min, at a 1 mL/min ﬂow rate.
2.3. Liposome preparation
Large unilamellar vesicles (LUVs) of 1,2-Dipalmitoyl-sn-Glycero-3-
[Phospho-rac-(1-glycerol)] (DPPG), 1,2-Dipalmitoyl-sn-Glycero-3-
[Phospho-L-Serine] (DPPS), 1,2-Dipalmitoyl-sn-Glycero-3-Phospho-
choline (DPPC), 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine(DPPE), 1,2-Dilauroyl-sn-Glycero-3-Phosphocholine (DLPC), 1,2-
Dimyristoyl-sn-Glycero-3-Phosphocholine (DMPC) and 1,2-Distearoyl-
sn-Glycero-3-Phosphoethanolamine (DSPE) were prepared by dissol-
ving each lipid in chloroform (except for DPPG,whichwas dissolved in a
chloroform/methanol 4:1 (v/v) mixture), then the solvent was slowly
evaporated under a N2 stream, yielding a dry lipid ﬁlm that was
subsequently submitted to a SpeedVac system for 2 h. The dry lipids
were hydrated inMilliQ water, then vortexed at temperatures above the
gel/liquid-crystalline phase transition temperature of the phospholi-
pids (41 °C, 41 °C, 63 °C, 54 °C, 23 °C,−1 °C and 74 °C for DPPG, DPPC,
DPPE, DPPS, DMPC, DLPC and DSPE, respectively), and ﬁnally the
multilamellar vesicles were extruded through a polycarbonate ﬁlter 11
times to yield LUVs with an average diameter of 100 nm.
2.4. Far-UV circular dichroism (CD) and secondary structural content of
Pln149a
The CD spectrum of Pln149a (0.1 mg/mL) in MilliQ water was
recorded from 190 to 250 nm on a JASCO J-715 spectropolarimeter
(Jasco Instruments, Tokyo, Japan) as an average of 16 scans, using a
0. 1-cm path length cylindrical quartz cuvette at 25 °C. The CD spectra
of Pln149a incubated with each different LUV were also recorded
under the conditions described above. Incubation was performed in a
1:20 peptide/lipid ratio.
The estimation of secondary structure elements in the peptide
structure was performed by CD spectrum deconvolution using CDPro
package [13], containing the ContinLL, Selcon3 and CDSSTR programs.
Additionally, the formalism of Chen et al. [14] was used to estimate the
helicoidal content (fhelix) based on both the ellipticity at 222 nm
(θ222 nm) and the number of amino acid residues (n), as in Eq. (1):
fhelix =
θ222 nm½ 
−39;500 · 1− 2:57 = nð Þ : ð1Þ
2.5. Steady-state ﬂuorescence
The ﬂuorescence emission spectra of Pln149a were obtained in an
ISS K2 spectroﬂuorimeter (ISS Fluorescence, Analytical and Biomedi-
cal Instruments, Illinois, USA), at 25 °C using a circulating water bath
(Fisher Scientiﬁc) around a 1-cm path length rectangular quartz
cuvette. Pln149a (0.1 mg/mL in MilliQ water) was excited at 274 nm
and the emission spectra were recorded from 290 to 450 nm.
Reference spectra were recorded and subtracted after each
measurement.
2.6. Surface tension and dilatational surface elasticity measurements
The kinetics of Pln149a adsorption on DPPG monolayers were
examinedwith surface tensionmeasurements using the axisymmetric
drop shape analysis method (OCA-20 from Dataphysics Instruments
GmvH, Germany), with the oscillating drop accessory ODG-20, as
previously described [15,16]. DPPG solution (0.1 mM) was prepared in
chloroform and methanol (4:1, v/v) and was gently spread on the
surface of a Pln149a solution drop (from 0.125 to 8.25 μM) to generate
a lipid monolayer. The drop was expanded up to 30 mN m−1,
corresponding to biomembrane surface packing [17]. Subsequent
changes in surface pressure due to peptide adsorption were plotted
against time. The dynamic dilatational surface elasticity data were
obtained after the surface tension reached equilibrium, using a
periodic drop oscillation of 0.1 mm amplitude (relative area variation
ΔA/A of 5.5%) and 1.0 Hz frequency. The viscous effect (imaginary
elasticity) of the surface elasticity was estimated from the phase
angle.
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Cultures of S. cerevisiae were grown overnight in yeast extract
peptone dextrose medium (YEPD). Ten microliters of this saturated
culture was used to inoculate 5 mL of YEPDmedium in the presence of
Pln149a (80 μM). A control culture was grown in the absence of the
peptide. Cultures were grown at 30 °C and 200 rpm; turbidity at
600 nm was monitored at 16 and 24 h.
2.8. Scanning electron microscopy (SEM)
Cultures of S. cerevisiaewere grown in YEPD culture medium in the
presence and in the absence of Pln149a (1 mg/mL). Different aliquots
of these cultures were taken at 6, 12 and 24 h of incubation and
observed by SEM. Aliquots of the culture (200 μL) were ﬁltered
through a cellulose-acetate membrane (0.45 μm) that was washed
with 0.9% NaCl to remove sample excess, and further ﬁxed in 2.5%
glutaraldehyde for 12 h, followed by washes with 100-mM sodium
phosphate (pH 7.4) and dehydration in a series of 50, 70, 80, 90, 95
and 100% ethanol. Critical point drying was promoted with HMDS
(hexamethyldisilazane). Specimens on stubs were coated with gold
and examined at 25 kV in a Zeiss-DSM 960 scanning electron
microscope (Oberkochen, Germany).Fig. 1. SEM of S. cerevisiae cells in the presence and absence (controls) of Pln149a (400 μM)
correspond to two aliquots of cells incubated in the presence of Pln149a taken after 6 h of incu
and images H and I correspond to 24 h of incubation. Bars=5 μm.3. Results and discussion
3.1. Pln149a synthesis and puriﬁcation
Peptide synthesis produces enough amounts of peptide to be used
in the investigation of its mechanism of action and activity against
microorganisms and biomembrane model systems.
After manual synthesis, the peptidyl-resin cleavage had an 85%
yield of the crude peptide, according to the resin capacity. On the C18
puriﬁcation, the major peptide fraction (78% of the crude peptide)
eluted at 38% of the acetonitrile gradient, as in Muller et al. [9],
corresponding to puriﬁed Pln149a that was further used for structural
characterization.
3.2. Pln149a action against S. cerevisiae
Pln149a was shown to inhibit S. cerevisiae growth by 82% in YPD
medium for up to 16 h, according to the turbidity decrease at 600 nm
in comparison to control culture. Even after incubation for 24 h, a 47%
growth reduction was observed, showing that the peptide remained
active and suggesting its probable resistance to the proteolytic action
of yeast proteases present in the culture medium after 24 h of
incubation.. Controls: A, D and G, at 6, 12 and 24 h of growth, respectively. The images in B and C
bation. As previous, the images in E and F correspond to 12 h of incubationwith Pln149a,
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Pln149a and also control cultures. The action on S. cerevisiae cells was
observed over a period ranging from 6 to 24 h of incubation.
Morphological changes in the yeast cell wall could be observed in
the culture with Pln149a even after 6 h of exposure. Additionally,
intact cells were rarely observed after 12 h of incubation, suggesting a
strong action of the peptide against the yeast cells. However, although
many antimicrobial peptides act at the cell membrane level [18], it
remains unclear if this is the case for Pln149a. Also, it not knownwith
which cellular component it interacts, since the mechanism through
which many of the α-helical antimicrobial peptides (AMPs) cause cell
death does not involve binding to speciﬁc receptors [19].
The observed inhibition of S. cerevisiae growth created interest in
studying the Pln149a mechanism of action, since the mechanism
proposed for Pln149a on bacteria (carpet mechanism) [9] does not
explain how Pln149a would act on yeast cell walls. The S. cerevisiae
cell wall has external and internal layers constituted of three principal
components: glucan, mannan and chitin [12], and the bacterial cell
surface is composed of negatively charged components, such as
lipopolysaccharide and teichoic acids. Thus, because the electrostatic
interaction between cationic AMPs and the negatively charged
bacterial cell surface should play an important role in their
antibacterial activity [20], we ﬁrst investigated Pln149a interaction
with some mono- and polysaccharides that present similar properties
to those of the S. cerevisiae cell wall.
3.3. Circular dichroism
No conformational changes in Pln149a CD spectra were observed
when incubated with a neutrally charged galactomannan, a negatively
charged carrageenan, or the neutral monosaccharide N-acetyl-
galactosamine, which suggests that Pln149a does not interact with
these polysaccharides or simple neutral monosaccharides (data not
shown). Therefore, the peptide passes through the S. cerevisiae cell
wall in a permeable way and interacts with the phospholipids from
the plasmamembrane, thus promoting a subsequent disruption of the
yeast cell wall. Using different membrane models (constructed with
the lipids DPPG, DPPC, DLPC, DMPC, DPPE, DSPE and DPPS), theFig. 2. Pln149a far-UV CD spectra. Pln149a (0.1 mg/mL) in water (solid line) and with
Measurements were taken from 190 to 250 nm as the average of 16 scans, at 25 °C and usiinteraction between Pln149a and the model systems has been
investigated by CD and ﬂuorescence spectroscopies.
Pln149a in aqueous medium shows an unordered structure in its
CD spectrum (Fig. 2), with a minimum at 197 nm as well as many
other small peptides in aqueous solution [21–23]. No conformational
changes were seen for this spectrum when the peptide was observed
in the presence of zwitterionic phosphocoline (DPPC) and phos-
phoethanolamine (DPPE) vesicles. Only in the presence of the
negatively charged DPPG liposomes did Pln149a present differences
in its native CD spectrum. This interaction induced conformational
changes in the Pln149a secondary structure that are compatible with
the presence of a helical element, assigned to the two negative
minima at 222 nm and 208 nm and the positive maximum at 196 nm.
This result can be attributed to the negative surface of the DPPG
vesicles, which provided a region where all the six basic Lys residues
could be electrostatically stabilized, resulting in a strong interaction
between them.
The interaction of Pln149a with the DPPS liposomes also
produced no alterations in the peptide CD spectrum, and it can be
assumed that this phospholipid did not provide a suitable environ-
ment for the interaction of this cationic peptide. The negative
regions of the serine group (the carboxylate-end and phosphate
groups) had a negative surface density, decreased by the presence of
the positive ammonium-end group located on the same serine of
the same phosphate head.
Pln149a CD spectra in aqueous solution and in the presence of the
different vesicles were used to estimate the percentage of helix
structure, using a reference set of 43 proteins [13]. From the CD spectra
deconvolution and quantiﬁcation, the helical induction of Pln149a
structure in the presence of DPPG vesicles was determined to be 16%,
with a 57% reduction of the unordered structure. This result agrees
with that calculated from the formalism of Chen, where 18% helicity
was estimated for Pln149a interacting with DPPG LUVs.
A coil-to-helix conformational change can also be seen in the struc-
ture of other antimicrobial peptides, either from amphibians [22, 24] or
from bacteria, like Plantaricin A [10]. These are all positively charged
peptides that undergo a helical inductionwhen interacting with anionic
species.liposomes of DPPG (dot), DPPS (dash), DPPC (dash dot) and DPPE (dash dot dot).
ng a 0.1-cm path length quartz cuvette.
Fig. 4. Dilational surface elasticity for Pln149a/DPPG mixed monolayers. Measurements
were taken at a frequency of 1 Hz, relative area deformation of 5.5% and temperature of
25 °C.
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amphipathic α-helix structure when binding to negative phospholi-
pids (like DPPG) have been shown to be compatible with the carpet
mechanism, proposed by Shai [25], for linear amphipathic α-helical
peptides. The amphipathic helix generates a polar side with a positive
net charge (due to Pln149a basic residues) that permits interactions
with negative species, and a more apolar environment on the other
helix side, where the hydrophobic residues of Pln149a can interact
favorably with the membrane aliphatic chains.
The static ﬂuorescence spectra of Pln149a measured after
excitation at 275 nm, in aqueous solution and in the presence of
the vesicles, revealed the same λmax at 303 nm seen for Tyr
residue emission when exposed to the aqueous phase [26], which
can be attributed to the N-terminal position of this aromatic residue
in the peptide. A small decrease in ﬂuorescence intensity was
observed in the presence of the phospholipid vesicles. Nevertheless,
it was more likely due to quenching caused by changes in the
chemical environment (from water to high density) than to the
peptide interaction, since it was noted for all liposomes tested (Fig.
2, inserted box).
3.4. Surface activity
From Fig. 3 it is apparent that Pln149a caused no surface tension
(γ) variation when spread on pure water subphase, even for the
highest concentration studied, 8.12 μM. This means that the peptide
did not present surface activity at the bare air–water interface in the
concentration range studied here. However, the kinetics of adsorption
of the peptide in the monolayer showed an induced surface activity
promoted by the presence of DPPG (Fig. 3). Furthermore, the curves
indicated a behavior dependent on the peptide concentration. From
0.125 to 2.06 μM, the adsorption kinetics presented similar behavior,
accentuated by the increasing peptide concentration. The curves are
characterized by a continuous decrease in the surface tension, but the
trend expected for a diffusion mechanism and the equilibrium of
adsorption are not reached in 500 s. On the other hand, the curves
corresponding to 4.12 and 8.25 μM of Pln149a showed different
behavior. Although the surface tension variation in the initial stages
was faster than the result for smaller concentrations, a steady state
(γeq) was apparently reached in these cases. Moreover, the γeq values
were increased as much as the concentration. This behavior was not
the one expected for a simple increase in the surface density with
spread concentration, which should promote a higher decrease in
surface tension. Thus, to better understand the interaction of Pln149aFig. 3. Adsorption kinetics of Pln149a. Peptide concentration ranging from 0.125 to
8.25 μM on DPPG monolayers.with the biomembrane model system, the DPPGmonolayer, dilational
surface elasticity (E) measurements were performed.
Fig. 4 presents the E data for DPPG monolayers in the presence of
different Pln149a concentrations in the subphase. For pure lipid, the
obtained E value was 228.3 mN m−1. Thus Pln149a decreased the E
values, compared to DPPG monolayer formed at the air–water
interface when present in concentrations below 2.06 μM. Similar
results were observed for the AMP PGLa [27], where the structure and
bending rigidity of DPPG monolayers formed at the liquid–liquid
interface in the presence of the antimicrobial peptide were investi-
gated and it was concluded that the peptide acts as a plasticizer for the
membrane. However, the authors did not investigate the effect of
peptide concentration for that system.
Coming back to Fig. 4, although for up to 1.65 μM of Pln149a, E
increased only slightly and seemed to reach a plateau, a steep increase
was observed above 2.5 μM. This change in behavior with concentra-
tion agrees with the adsorption kinetics data, for which a change was
also reported above 2.06 μM. At 2.5 μM, a maximum was reached,
surpassing the value for pure DPPG monolayer. After this point, an
inversion in the behavior of the system was observed, and E values
started to decrease, indicating an increase in the ﬂuidity of the model
membrane.
Different studies in the literature have reported the effect of an
antimicrobial peptide onmembrane ﬂuidity. It has been observed that
oleuropein [28] expands different lipid monolayers, including polar
lipids extracted from E. coli, suggesting that it is incorporated into the
lipid monolayer. This assumption is corroborated by the surface
elasticity data that presented lower values for the peptide. Another
antimicrobial peptide, dicynthaurin [29], expands the DPPG mono-
layer because it accumulates on the monolayer. Furthermore, the
presence of cynthaurin destabilizes the membrane model even at
higher surface pressure values (30 mN m−1) [17], as conﬁrmed by
GIXD and epiﬂuorescence microscopy, and the ﬂuidization of the
condensed chain lattice suggests that the peptide is able to expand the
bacterial membrane, which would be relevant for the in vivo mode of
action.
In Fig. 5, a model of the interaction between Pln149a and the DPPG
monolayer, showing the induction of structural changes in the peptide
structure, followed by the monolayer disruption is proposed. Firstly,
the disordered structure-like peptide in bulk solution is electrostatic
attracted to the charged phospholipids, promoting a peptide accu-
mulation on the monolayer surface. The amphipathic peptide remains
associated with the negatively phospholipids by its hydrophilic region
Fig. 5. Proposed model for Pln149a/DPPG monolayer interaction. Pln149a presents a random-coil structure in aqueous solution (1), but it is electrostatically attracted to a negative
surface (like DPPG), inducing an amphipathicα-helix in its structure (2). The surface packing of the monolayer is gradually altered to accommodatemore andmore Pln149a from the
solution (3), resulting in the disruption of the lipid monolayer (4).
2257J.L.S. Lopes et al. / Biochimica et Biophysica Acta 1788 (2009) 2252–2258and, at the same time, the N-terminal residues (its more hydrophobic
region) is inserted among the acyl chains of the phospholipids,
altering the surface packing of the monolayer and promoting its
disruption.
4. Conclusions
The observed action of Pln149a against S. cerevisiae suggests
additional potential applications for this peptide in the food industry
or as a non-enzymatic/non-mechanical process for disrupting cells.
Only the negatively charged DPPG was able to induce structural
changes in Pln149a, as shown by the CD spectra changes recorded for
DPPG LUVs in the presence of Pln149a. In contrast, the spectra
recorded for the unordered Pln149a in solution and for liposomes
prepared with DPPS, DPPE and DPPC were quite similar. Therefore,
stabilization of the helix induced on Pln149a structure appears to be
an important step of the “binding” that occurs by electrostatic
interactions between the positively charged residues of the peptide
and the anionic phospholipid heads. In addition, it can be assumed
that the helical form imposed on the Pln149a structure is proportional
to the driving forces that generate the attraction between these two
species. That is, the interaction depends on both the electrical charge
density of the phospholipids and the special features of Pln149a
segments, such as the positive charge distribution and likelihood of
hydrophobic portions being hidden inside the loops of the helix.
Analyzing the surface data, some important observations can be
made about the mechanism of interaction between the peptide and
the monolayer. Pln149a initially interacts with DPPG, adsorbing and
accumulating at the lipid–air interface, as can be seen from the
adsorption kinetics. This process becomes more effective as the
concentration of peptide increases. On the other hand, the surface
elasticity decreases, most likely because small amounts of peptide
change the surface packing of the monolayer, resulting in a mixed and
more ﬂuid monolayer than that of pure DPPG. In fact, insertions of the
peptide within the polar head group region should require space,
disturbing the acyl chain packing.
However, increasing the peptide concentration produces a system
with an elevated dilational elasticity modulus. This ﬁnding can only be
explained if we assume that themanner inwhich the peptide interacts
with the monolayer changes. If we examine the CD data for DPPG
liposomes in the presence of Pln149a, we might assume that above a
certain concentration the electrostatic interaction operates coopera-
tively, inducing a helix structure in the peptide that remains below the
head groups, shielding the electrical charge of the negatively charged
head groups and bringing them closer. This picture explains the
elevated E values measured for higher Pln149a concentrations.
However, there is a limit for this kind of interaction, because above
2.5 μM the steep decrease in E is attributed to a disruption in the
monolayer by a solubilization mechanism.
A similar mechanism probably takes place on the yeast cells (as
observed in Fig. 1), in which the yeast membrane cell disruption leadsaway the wall cell disorganization, generating the aggregated
(probably membrane and wall cells) and/or deformed cells (as in
boxes C, F and G).
In summary, all the results taken together have led us to conclude
that Pln149a is an amphipathic α-helical antimicrobial peptide that
initially binds to the surface of negatively charged membranes,
ultimately covering it in a carpet-like manner. Once the critical
concentration of Pln149a is reached (close to 2.5 μM), the lipid layer is
disrupted.
To better describe the mechanism of action of Pln149 in biologic
membranes, its action against different classes of microorganisms, as
well studies of other Pln149-derived peptides, with the aim of
obtaining a peptide with potential activity are in current investigation
in our group.
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